JP2008503574A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008503574A5 JP2008503574A5 JP2007518003A JP2007518003A JP2008503574A5 JP 2008503574 A5 JP2008503574 A5 JP 2008503574A5 JP 2007518003 A JP2007518003 A JP 2007518003A JP 2007518003 A JP2007518003 A JP 2007518003A JP 2008503574 A5 JP2008503574 A5 JP 2008503574A5
- Authority
- JP
- Japan
- Prior art keywords
- sodium salt
- esomeprazole
- diffraction pattern
- ray powder
- powder diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58261704P | 2004-06-24 | 2004-06-24 | |
| US60/582,617 | 2004-06-24 | ||
| PCT/SE2005/000954 WO2006001753A1 (en) | 2004-06-24 | 2005-06-20 | New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012203798A Division JP2012246316A (ja) | 2004-06-24 | 2012-09-18 | エソメプラゾールのナトリウム塩の製造に使用するための結晶の改変型の作成方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008503574A JP2008503574A (ja) | 2008-02-07 |
| JP2008503574A5 true JP2008503574A5 (enExample) | 2008-07-31 |
| JP5457632B2 JP5457632B2 (ja) | 2014-04-02 |
Family
ID=35782078
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007518003A Expired - Fee Related JP5457632B2 (ja) | 2004-06-24 | 2005-06-20 | エソメプラゾールのナトリウム塩の製造に使用するための結晶の改変型の作成方法 |
| JP2012203798A Pending JP2012246316A (ja) | 2004-06-24 | 2012-09-18 | エソメプラゾールのナトリウム塩の製造に使用するための結晶の改変型の作成方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012203798A Pending JP2012246316A (ja) | 2004-06-24 | 2012-09-18 | エソメプラゾールのナトリウム塩の製造に使用するための結晶の改変型の作成方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8658799B2 (enExample) |
| EP (1) | EP1765806A1 (enExample) |
| JP (2) | JP5457632B2 (enExample) |
| KR (2) | KR20130140918A (enExample) |
| CN (3) | CN103121992A (enExample) |
| AU (1) | AU2005257709C1 (enExample) |
| BR (1) | BRPI0512522A (enExample) |
| CA (1) | CA2570795C (enExample) |
| HK (1) | HK1197065A1 (enExample) |
| MX (1) | MXPA06015031A (enExample) |
| NZ (1) | NZ551970A (enExample) |
| WO (1) | WO2006001753A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1907375B1 (en) * | 2005-06-08 | 2013-07-24 | LEK Pharmaceuticals d.d. | Crystalline solvate of omeprazole sodium |
| WO2007055178A1 (ja) * | 2005-11-08 | 2007-05-18 | Japan Health Sciences Foundation | 細胞の分取方法、及び当該方法に用いる基材 |
| US8063074B2 (en) | 2006-05-04 | 2011-11-22 | Dr. Reddy's Laboratories Limited | Polymorphic forms of esomeprazole sodium |
| EP2143722A1 (en) | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| MX2012009220A (es) | 2010-02-12 | 2012-09-07 | Esteve Quimica Sa | Procedimiento de preparacion de la sal sodica de esomeprazol. |
| CN102746272B (zh) * | 2012-04-11 | 2014-06-25 | 江苏奥赛康药业股份有限公司 | 一种埃索美拉唑钠多晶型物及其制备方法和应用 |
| CN102746273A (zh) * | 2012-05-29 | 2012-10-24 | 江苏奥赛康药业股份有限公司 | 一种埃索美拉唑钠多晶型物及其在注射用药物中的应用 |
| CN104031032B (zh) * | 2014-07-04 | 2016-04-27 | 江苏奥赛康药业股份有限公司 | 一种埃索美拉唑钠化合物及其药物组合物 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4378974A (en) | 1982-06-09 | 1983-04-05 | Allis-Chalmers Corporation | Start-up method for coal gasification plant |
| SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
| NZ244301A (en) * | 1991-09-20 | 1994-08-26 | Merck & Co Inc | Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds |
| US6875872B1 (en) | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
| SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| WO1995032957A1 (en) * | 1994-05-27 | 1995-12-07 | Astra Aktiebolag | Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles |
| SE504459C2 (sv) | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
| SE510666C2 (sv) * | 1996-12-20 | 1999-06-14 | Astra Ab | Nya Kristallmodifikationer |
| SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
| SE510643C2 (sv) * | 1997-06-27 | 1999-06-14 | Astra Ab | Termodynamiskt stabil omeprazol natrium form B |
| NL1007699C2 (nl) | 1997-12-04 | 1999-06-09 | Medisize Bv | Beademingssysteem. |
| SE9900274D0 (sv) * | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
| EP1206466B1 (en) * | 1999-08-26 | 2005-10-12 | aaiPharma Inc. | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| AU2001276721A1 (en) | 2000-08-04 | 2002-02-18 | Takeda Chemical Industries Ltd. | Salts of benzimidazole compound and use thereof |
| WO2003089408A2 (en) | 2002-04-22 | 2003-10-30 | Sun Pharmaceutical Industries Limited | Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts |
| WO2004002982A2 (en) | 2002-06-27 | 2004-01-08 | Dr. Reddy's Laboratories Limited | A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| EA200500673A1 (ru) | 2002-10-22 | 2005-12-29 | Рэнбакси Лабораториз Лимитед | Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе |
| DK1578742T3 (da) * | 2002-12-06 | 2013-01-21 | Nycomed Gmbh | Fremgangsmåde til fremstilling af optisk rene aktive forbindelser |
| AU2003238671A1 (en) | 2003-04-10 | 2004-11-01 | Hetero Drugs Limitd | Novel crystalline forms of s-omeprazole magnesium |
| MXPA05013316A (es) | 2003-06-10 | 2006-03-17 | Teva Pharma | Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol. |
-
2005
- 2005-06-20 BR BRPI0512522-7A patent/BRPI0512522A/pt not_active IP Right Cessation
- 2005-06-20 CN CN2013100244957A patent/CN103121992A/zh active Pending
- 2005-06-20 AU AU2005257709A patent/AU2005257709C1/en not_active Ceased
- 2005-06-20 CA CA2570795A patent/CA2570795C/en not_active Expired - Fee Related
- 2005-06-20 JP JP2007518003A patent/JP5457632B2/ja not_active Expired - Fee Related
- 2005-06-20 MX MXPA06015031A patent/MXPA06015031A/es active IP Right Grant
- 2005-06-20 US US11/570,717 patent/US8658799B2/en not_active Expired - Fee Related
- 2005-06-20 KR KR1020137032748A patent/KR20130140918A/ko not_active Ceased
- 2005-06-20 CN CN201410063477.4A patent/CN103772360A/zh active Pending
- 2005-06-20 WO PCT/SE2005/000954 patent/WO2006001753A1/en not_active Ceased
- 2005-06-20 KR KR1020137005546A patent/KR20130038949A/ko not_active Withdrawn
- 2005-06-20 NZ NZ551970A patent/NZ551970A/en not_active IP Right Cessation
- 2005-06-20 EP EP05754053A patent/EP1765806A1/en not_active Ceased
- 2005-06-20 CN CNA2005800208742A patent/CN1972928A/zh active Pending
-
2012
- 2012-09-18 JP JP2012203798A patent/JP2012246316A/ja active Pending
-
2014
- 2014-10-23 HK HK14110572.9A patent/HK1197065A1/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006526031A5 (enExample) | ||
| JP2004503501A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| JP2007302683A5 (enExample) | ||
| JP2011524903A5 (enExample) | ||
| JP2008518890A5 (enExample) | ||
| WO2007107470A3 (en) | Pyrazoles as 11-beta-hsd-1 | |
| JP2003503454A5 (enExample) | ||
| JP2006298933A5 (enExample) | ||
| WO2007060140A3 (en) | Inhibitors of diacyglycerol acyltransferase (dgat) | |
| JP2005518433A5 (enExample) | ||
| JP2012144574A5 (enExample) | ||
| JP2008528441A5 (enExample) | ||
| WO2009010416A3 (en) | Inhibitors of 11b-hydroxysteroid dehydrogenase | |
| JP2009500423A5 (enExample) | ||
| JP2007519721A5 (enExample) | ||
| JP2005536503A5 (enExample) | ||
| CN115315423A (zh) | 取代芳基类化合物 | |
| JP2010520174A5 (enExample) | ||
| CA2530308A1 (en) | 5ht2c receptor agonists for the treatment of diabetes and obesity | |
| JP2011046708A5 (enExample) | ||
| JP2009040767A5 (enExample) | ||
| JP2008501036A5 (enExample) | ||
| JP2009532434A5 (enExample) | ||
| NZ560669A (en) | Use of alkyl cellulose as controlled release matrix material in alcohol resistant dosage forms |